A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer, NBC News reported. The test isn't meant to replace colonoscopies, but is ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

A new FDA-approved blood test designed to detect colon cancer earlier is now available in North Texas. An estimated 154,270 people in the U.S. will be diagnosed with colorectal cancer this year. It's ...

The American Cancer Society recommends that people at average risk of colorectal cancer start regular screening at age 45, and several blood tests on the market could help. These tests are done in a ...

Colon cancer is a leading cause of cancer-related deaths. It typically begins as a small growth of tissue called a polyp in the lining of the colon or rectum. While not all polyps become cancerous, ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

Liquid biopsies have transformed cancer testing. These tests detect signs of cancer using a simple blood draw instead of removing tissue from the body. Traditional biopsies involve surgery, needles, ...

Colorectal cancer is the second most common cancer and the third leading cause of cancer related deaths in men and women under age 50. According to the American Cancer Society almost 153,000 ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...